2024 Agenda
Download Presentation
- Download Presentation
Thursday, July 25
Friday, July 26
Saturday, July 27
Sunday, July 28
Thursday, July 25
Time
Topic
Speaker
Moderator: Josh Simmons, MD, FACP
Breast Cancer
7:40 AM
Omission of Surgical Staging of the Axilla in Breast Cancer: When and Why
7:55 AM
DEBATE
Is PMRT Needed in Patients with Nodal pCR Following Neoadjuvant Chemotherapy?
8:15 AM
Treatment Approaches after CDK4/6 Inhibition in HR+/HER2-Negative MBC
8:45 AM
DEBATE
Is There Still a Role for Anthracycline in Early Stage Breast Cancer?
Head and Neck
10:10 AM
Improving the Standard in Locally Advanced SCCHN: An Elusive or Delayed Reality?
10:25 AM
DEBATE
Surgical Resection Without Pre-Op Immunotherapy is the Preferred Therapeutic Approach for Locally Advanced Skin SCC
Lecture of the Day
Moderator: Andrew Johnson, MD
Leukemia
12:05 PM
Molecular Testing in Hematologic Malignancies: What Does Every Patient Need at a Minimum?
1:35 PM
Evolving Frontline ALL Therapy: Incorporating Novel BCR-ABL TKIs and Immunotherapies
Friday, July 26
Time
Topic
Speaker
Moderator: Eric Turner, MD
Brain Cancers
Melanoma
8:35 AM
DEBATE
Using Pathological Response to Determine De-Escalation of Surgery and Need for Adjuvant Therapy
Genitourinary Cancers
9:25 AM
DEBATE
Triplet vs Doublet in M1 Castration-Sensitive Prostate Cancer
- Bassel Nazha, MD, MPH
- vs
- Jordan Ciuro, MD
9:45 AM
PSMA-Targeted Radioligand Therapy in the Management of Prostate Cancer: A Genitourinary Oncologist’s Perspective
Lecture of the Day
11:05 AM
How Can the Cardio-oncologist Partner with You?
Q&A moderated by Medical Oncology fellow
11:25 AM
Lunch and Introduction to the Georgia Blood Cancer Trials Network
Moderator: Gregory Harris, DO, FACOI
Lymphoma
12:50 PM
DEBATE
MRD is an Important Clinical Endpoint in Frontline Management of CLL
1:25 PM
DEBATE
Optimal Management of Advanced Stage HL: Nivo-AVD vs BV-AVD
Saturday, July 27
Time
Topic
Speaker
Moderator: Andrew Pippas, MD
Gastrointestinal Cancers
8:05 AM
DEBATE
Immuno-Oncology in Perioperative Therapy for Early Gastroesophageal Cancer: To Add or Not to Add?
- Oluwadunni Emiloju, MBBS, MS
- vs
- Lindsay Hannan, MD, MSc
8:25 AM
DEBATE
Is First-Line PRRT in GEP-NETs the Standard of Care?
8:45 AM
DEBATE
Role of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Ready for Prime Time?
Lecture of the Day
Gynecologic Cancers
10:25 AM
Low-Grade Epithelial Ovarian Cancer: Optimizing Targeted and Hormonal Agent Options
10:40 AM
HER-2/neu-Directed Therapy: Not Just for Breast Cancer Anymore
10:55 AM
DEBATE
Moving Immunotherapy to the Frontline with Chemoradiation in Locally Advanced Cervical Cancer
11:15 AM
Dear Investigator Letters: Current Role of PARP Inhibitors in Ovarian Cancer
Moderator:
Myeloma
12:45 PM
DEBATE
BCMA vs GPRC5D as Targets for Multiple Myeloma
1:20 PM
DEBATE
Transplant vs No Transplant for AL Amyloidosis
Sunday, July 28
Time
Topic
Speaker
Moderator:
Thoracic Cancer
8:20 AM
DEBATE
Continuing Immunotherapy After Complete Pathologic Response with Neoadjuvant Therapy
9:10 AM